The Rosen Law Firm, P.A.
Search documents
CRWV DEADLINE ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages CoreWeave, Inc. Investors to Secure Counsel Before Important March 13 Deadline in Securities Class Action – CRWV
Globenewswire· 2026-03-01 16:06
Core Points - Rosen Law Firm is reminding investors who purchased CoreWeave, Inc. securities between March 28, 2025, and December 15, 2025, of the March 13, 2026, lead plaintiff deadline for a class action lawsuit [1] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] Class Action Details - A class action lawsuit has been filed against CoreWeave, alleging that the company made false and misleading statements regarding its ability to meet customer demand and the risks associated with reliance on a single third-party data center supplier [4] - The lawsuit claims that these misstatements were likely to have a material negative impact on CoreWeave's revenue, leading to investor damages when the truth was revealed [4] Legal Representation - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions, as many firms may not have the necessary experience [3] - Rosen Law Firm has a history of significant recoveries for investors, including over $438 million in 2019 alone, and has been recognized for its leadership in securities class action settlements [3]
LAKE Investors Have Opportunity to Lead Lakeland Industries, Inc. Securities Fraud Lawsuit
Prnewswire· 2026-02-27 22:39
Core Viewpoint - A class action lawsuit has been filed against Lakeland Industries, Inc. for securities fraud, alleging that the company made false and misleading statements regarding its business operations and financial results during the Class Period from December 1, 2023, to December 9, 2025 [1]. Group 1: Lawsuit Details - The lawsuit claims that Lakeland was facing significant issues with its Pacific Helmets and Jolly businesses, including shipping delays, production issues, and a slower rollout of new products [1]. - Defendants allegedly overstated the positive impact of these businesses on Lakeland's financial results and the overall strength of their operations [1]. - The lawsuit indicates that Lakeland's financial results were deteriorating due to tariff-related headwinds, certification delays, and material flow issues in its acquired businesses [1]. Group 2: Financial Guidance and Public Statements - The defendants are accused of overstating the effectiveness of their tariff mitigation measures and their "small, strategic, and quick" M&A strategy [1]. - As a result of the aforementioned issues, the financial guidance provided by the defendants was deemed unreliable [1]. - The lawsuit asserts that the public statements made by the defendants were materially false and misleading throughout the Class Period [1].
BRBR Deadline: BRBR Investors Have Opportunity to Lead BellRing Brands, Inc. Securities Fraud Lawsuit
Prnewswire· 2026-02-27 21:09
BRBR Deadline: BRBR Investors Have Opportunity to Lead BellRing Brands, Inc. Securities Fraud Lawsuit [Accessibility Statement] Skip NavigationNEW YORK, Feb. 27, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bellring Brands, Inc. (NYSE: BRBR) between November 19, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), of the important March 23, 2026 lead plaintiff deadline.So what: If you purchased BellRing securities during the C ...
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit
Prnewswire· 2026-02-27 20:53
VTGN Deadline: VTGN Investors Have Opportunity to Lead Vistagen Therapeutics, Inc. Securities Fraud Lawsuit [Accessibility Statement] Skip NavigationNEW YORK, Feb. 27, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Vistagen Therapeutics, Inc. (NASDAQ: VTGN) between April 1, 2024 and December 16, 2025, both dates inclusive (the "Class Period"), of the important March 16, 2026 lead plaintiff deadline.So what: If you purchased Vistagen common s ...
ARDT FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Ardent Health, Inc. Investors to Secure Counsel Before Important March 9 Deadline in Securities Class Action - ARDT
Globenewswire· 2026-02-27 20:03
Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities between July 18, 2024, and November 12, 2025, of the March 9, 2026, deadline to become a lead plaintiff in a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Ardent Health securities during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [2] - The lead plaintiff must file a motion with the Court by March 9, 2026, to represent other class members in the litigation [2] Group 2: Law Firm Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3] - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions for investors [3] - In 2019, the firm secured over $438 million for investors, and its founding partner was recognized as a Titan of Plaintiffs' Bar by Law360 in 2020 [3] Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable and the processes used to determine their collectability [4] - Defendants claimed to employ an active monitoring process for accounts receivable, but the actual method involved a 180-day cliff for reserving accounts, leading to inflated reported amounts [4] - The firm also alleged that Ardent Health did not maintain sufficient professional malpractice liability insurance, which was inadequate to cover claims due to rising social inflationary pressures in medical malpractice cases [4]
SNOW Investors Have Opportunity to Lead Snowflake Inc. Securities Fraud Lawsuit
Prnewswire· 2026-02-25 22:58
Core Viewpoint - A class action lawsuit has been announced against Snowflake Inc. for securities fraud, involving purchasers of Class A common stock between June 27, 2023, and February 28, 2024, with the opportunity for investors to serve as lead plaintiffs [1]. Group 1: Lawsuit Details - The lawsuit claims that during the class period, Snowflake's management made positive statements about business performance while failing to disclose significant negative impacts on consumption and revenues due to product efficiency gains and pricing strategies [1]. - Investors who purchased Snowflake Class A common stock during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - The Rosen Law Firm, which is leading the lawsuit, has a strong track record in securities class actions, having recovered hundreds of millions of dollars for investors in the past [1]. Group 2: Next Steps for Investors - Interested investors can join the class action by visiting the provided link or contacting the law firm directly for more information [1]. - A lead plaintiff must be appointed by April 27, 2026, to represent the interests of the class members in the litigation [1]. - Until a class is certified, investors are not represented by counsel unless they retain one, and they may choose to remain absent from the class [1].
ARDT Deadline: ARDT Investors Have Opportunity to Lead Ardent Health, Inc. Securities Fraud Lawsuit
Prnewswire· 2026-02-24 22:28
Core Viewpoint - Rosen Law Firm is reminding investors who purchased Ardent Health, Inc. securities during the specified Class Period of the upcoming lead plaintiff deadline on March 9, 2026, for a class action lawsuit [1]. Group 1: Class Action Details - Investors who bought Ardent Health securities between July 18, 2024, and November 12, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [1]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the March 9, 2026 deadline [2]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm specializes in securities class actions and has a strong track record, including the largest securities class action settlement against a Chinese company [3]. - The firm has been ranked No. 1 for securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013, recovering hundreds of millions of dollars for investors [3]. Group 3: Case Allegations - The lawsuit alleges that Ardent Health made misrepresentations regarding its accounts receivable, claiming to employ an active monitoring process that was not actually utilized [4]. - It is claimed that Ardent Health did not maintain sufficient professional malpractice liability insurance, contrary to its public statements, leading to inflated accounts receivable reporting [4].
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages PennyMac Financial Services, Inc. Investors to Inquire About Securities Class Action Investigation – PFSI
Globenewswire· 2026-02-23 21:12
NEW YORK, Feb. 23, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of PennyMac Financial Services, Inc. (NYSE: PFSI) resulting from allegations that PennyMac may have issued materially misleading business information to the investing public. SO WHAT: If you purchased PennyMac securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fe ...
DNOW Investor News: Rosen Law Firm Encourages DNOW Inc. Investors to Inquire About Securities Class Action Investigation - DNOW
Prnewswire· 2026-02-22 04:00
Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of DNOW Inc. due to allegations of materially misleading business information issued by the company [1] Financial Performance - DNOW Inc. reported disappointing fourth-quarter 2025 financial results, which included a significant loss and missed Wall Street's expectations [1] - Following the announcement of these results, DNOW stock fell by 19.1% on February 20, 2026 [1] Legal Action - Investors who purchased DNOW Inc. securities may be entitled to compensation through a contingency fee arrangement without any out-of-pocket costs [1] - Rosen Law Firm is preparing a class action to seek recovery of investor losses [1] Firm Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company [1] - The firm was ranked No. 1 by ISS Securities Class Action Services for the number of securities class action settlements in 2017 and has consistently ranked in the top 4 since 2013 [1] - In 2019, the firm secured over $438 million for investors [1]
CRWV Deadline: CRWV Investors with Losses in Excess of $100K Have Opportunity to Lead CoreWeave, Inc. Securities Fraud Lawsuit
Prnewswire· 2026-02-21 23:15
Core Points - The Rosen Law Firm is reminding investors who purchased CoreWeave, Inc. securities between March 28, 2025, and December 15, 2025, of a lead plaintiff deadline on March 13, 2026 [1] - Investors may be entitled to compensation through a contingency fee arrangement without any out-of-pocket costs [1] - A class action lawsuit has been filed against CoreWeave, alleging that the company made false and misleading statements regarding its ability to meet customer demand and the risks associated with reliance on a single third-party data center supplier [1] Legal Context - The lawsuit claims that CoreWeave overstated its capacity to meet customer demand and understated the risks related to its data center supplier, which could negatively impact revenue [1] - Investors are encouraged to select qualified legal counsel with a successful track record in securities class actions [1] - The Rosen Law Firm has a history of significant settlements in securities class actions, including a record settlement against a Chinese company [1]